title: Plasmacytoid lymphoma treated with rituximab as first-line monotherapy.
authors.forename: Isabel
authors.initials: I
authors.lastname: Blancas
authors.forename: Irene
authors.initials: I
authors.lastname: Zarcos
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Gómez
authors.forename: María Teresa
authors.initials: MT
authors.lastname: Delgado
authors.forename: Josefa
authors.initials: J
authors.lastname: Carrillo
authors.forename: Marta
authors.initials: M
authors.lastname: Legerén
authors.forename: Belén
authors.initials: B
authors.lastname: Ríos
authors.forename: Eduardo
authors.initials: E
authors.lastname: Pacios
authors.forename: José Miguel
authors.initials: JM
authors.lastname: Jurado
authors.forename: María José
authors.initials: MJ
authors.lastname: Sánchez
authors.forename: Rocío
authors.initials: R
authors.lastname: Fonseca
authors.forename: José Luis
authors.initials: JL
authors.lastname: García Puche
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008221:Lymphoid Tissue / Q000473:pathology*; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D049268:Positron-Emission Tomography; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab